PCSK9 Inhibitor, EGF-A is a PCSK9 inhibitor. PCSK9 Inhibitor, EGF-A is residues 293-334 of the EGF-A domain of the low-density lipoprotein (LDL) receptor. PCSK9 Inhibitor, EGF-A can prevent PCSK9-induced intracellular LDLR degradation. PCSK9 Inhibitor, EGF-A can be used in the study of hypercholesterolemia and premature atherosclerosis[1].
Molecular Weight:
4597.07
Formula:
C188H292N58O65S6
Target:
PCSK9
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted